Developing new reporting guidelines for the early-stage clinical evaluation of decision support systems driven by artificial intelligence.
Much like IDEAL 2a/2b studies, robust early formative evaluation, with an emphasis on the human users, is a necessary bridge from the development of clinical decision support systems driven by artificial intelligence (AI) to their implementation and paves the way toward large-scale summative evaluation. The objective of DECIDE-AI is to improve reporting along four main axes:
A Delphi process with an international group of over 120 experts is currently being conducted and the guidelines are expected for the second half of 2021.
Link to Correspondence in Nature Medicine: https://www.nature.com/articles/s41591-021-01229-5
Link to the systematic review performed as part of the preliminary investigations: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777403
Contact: Baptiste Vasey, email@example.com